MK 8237
/ Merck (MSD)
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
April 16, 2018
House Dust Mite Sublingual Immunotherapy for Pediatric Patients With Allergic Asthma.
(PubMed, Ann Pharmacother)
- "Sublingual HDM immunotherapy reduces symptom scores in pediatric patients with allergic asthma but may be slower in onset and less effective than SCIT in reducing asthma medication use."
Clinical • Journal
1 to 1
Of
1
Go to page
1